Skip to content
10-Q

Quarterly Report

WEIKANG BIO-TECHNOLOGY GROUP CO., INC.

0001144204-11-066046

← back to feed
Filed
Nov 21, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2011 · Nov 18, 2011 34.39M sh
Stockholders Equity Q3 2011 · Sep 30, 2011 $97.6M
Current Liabilities Q3 2011 · Sep 30, 2011 $3.9M
Current Liabilities Q3 2011 · Dec 31, 2010 $8.21M
Current Assets Q3 2011 · Sep 30, 2011 $63.56M
Current Assets Q3 2011 · Dec 31, 2010 $52.55M
Total Assets Q3 2011 · Sep 30, 2011 $105.04M
Total Assets Q3 2011 · Dec 31, 2010 $78.61M
Shares Diluted Q3 2011 · Sep 30, 2010 28.05M sh
Shares Diluted Q3 2011 · Sep 30, 2010 27.81M sh
Capex Q3 2011 · Sep 30, 2010 $14.35K
Operating Cash Flow Q3 2011 · Sep 30, 2010 $16.33M
Cash And Equivalents Q3 2011 · Sep 30, 2010 $29.95M
Cash And Equivalents Q3 2011 · Dec 31, 2009 $11.38M
Eps Diluted Q3 2011 · Sep 30, 2010 $0.22
Eps Diluted Q3 2011 · Sep 30, 2010 $0.45
Eps Basic Q3 2011 · Sep 30, 2010 $0.22
Eps Basic Q3 2011 · Sep 30, 2010 $0.45
Sga Expense Q3 2011 · Sep 30, 2010 $755.64K
Sga Expense Q3 2011 · Sep 30, 2010 $3.37M
Rd Expense Q3 2011 · Sep 30, 2010 $957.72K
Rd Expense Q3 2011 · Sep 30, 2010 $1.76M
Net Income Q3 2011 · Sep 30, 2010 $6.07M
Net Income Q3 2011 · Sep 30, 2010 $12.52M
Operating Income Q3 2011 · Sep 30, 2010 $8.13M
Operating Income Q3 2011 · Sep 30, 2010 $17.35M
Gross Profit Q3 2011 · Sep 30, 2010 $10.46M
Gross Profit Q3 2011 · Sep 30, 2010 $24.9M
Cost Of Revenue Q3 2011 · Sep 30, 2010 $6.96M
Cost Of Revenue Q3 2011 · Sep 30, 2010 $16.98M
Revenue Q3 2011 · Sep 30, 2010 $17.43M
Revenue Q3 2011 · Sep 30, 2010 $41.88M